353 related articles for article (PubMed ID: 17890932)
1. Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis.
Donsky H; Clarke D
Am J Ther; 2007; 14(5):442-6. PubMed ID: 17890932
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, vehicle-controlled, half-side comparison with a herbal ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica for the treatment of mild-to-moderate atopic dermatitis.
Klövekorn W; Tepe A; Danesch U
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):583-91. PubMed ID: 18077922
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract--a double-blind, placebo-controlled study.
Bernstein S; Donsky H; Gulliver W; Hamilton D; Nobel S; Norman R
Am J Ther; 2006; 13(2):121-6. PubMed ID: 16645428
[TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
Abramovits W; Oquendo M
Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
[TBL] [Abstract][Full Text] [Related]
5. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
[TBL] [Abstract][Full Text] [Related]
6. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
Fleischer AB; Abramovits W; Breneman D; Jaracz E;
J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
9. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
[TBL] [Abstract][Full Text] [Related]
10. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
11. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
Boguniewicz M; Zeichner JA; Eichenfield LF; Hebert AA; Jarratt M; Lucky AW; Paller AS
J Pediatr; 2008 Jun; 152(6):854-9. PubMed ID: 18492531
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
13. Effect of standard medication on quality of life of patients with atopic dermatitis.
Kawashima M; Harada S
J Dermatol; 2007 Jan; 34(1):9-16. PubMed ID: 17204095
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
15. Proof of efficacy of Kamillosan(R) cream in atopic eczema.
Patzelt-Wenczler R; Ponce-Pöschl E
Eur J Med Res; 2000 Apr; 5(4):171-5. PubMed ID: 10799352
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
17. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
18. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Veraldi S; De Micheli P; Schianchi R; Lunardon L
J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]